The PCOS Challenge Study
PCOSCHALLENGE
1 other identifier
observational
15,000
1 country
1
Brief Summary
The primary purpose of The PCOS Challenge Study will be to conduct high-quality research where patients are included in the design, and answering the questions that patients identify as important to their lived experience with PCOS. In partnership with clinical investigators, patients will work on the development and management of data collection, the research agenda, and the sharing of research findings. The PCOSC Study will promote the advancement of research that provides reliable, useful, and meaningful information to patients with PCOS and their clinicians. The population for The PCOS Challenge Study will include individuals with a clinical diagnosis of PCOS, individuals self-diagnosed with PCOS, individuals with symptoms of PCOS (e.g., hirsutism, irregular menstrual cycles), and demographic-matched controls without PCOS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2022
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 22, 2022
CompletedFirst Submitted
Initial submission to the registry
March 22, 2023
CompletedFirst Posted
Study publicly available on registry
April 4, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2042
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2042
April 4, 2023
March 1, 2023
20 years
March 22, 2023
March 22, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Information
Such as responses to survey questions
One Year
Study Arms (2)
Target Population
The target population includes individuals diagnosed with PCOS by a healthcare provider, self-diagnosed with PCOS, or who are exhibiting PCOS Symptoms and willing to sign the consent.
Control Population
The control population includes people born biologically female who have not been diagnosed with PCOS and who also do not have symptoms of PCOS.
Eligibility Criteria
The population for The PCOS Challenge Study will include individuals with a clinical diagnosis of PCOS, individuals self-diagnosed with PCOS, individuals with symptoms of PCOS (e.g., hirsutism, irregular menstrual cycles), and demographic-matched controls without PCOS.
You may qualify if:
- Diagnosed with PCOS by a health professional, self-diagnosed with PCOS or individuals with PCOS symptoms
- Willing to sign the consent form
- Able to understand the registry surveys or what is being asked
You may not qualify if:
- Unable to understand the surveys or what is being asked
- Unwilling to sign the consent form
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
PCOS Challenge: The National Polycystic Ovary Syndrome Association
Bethesda, Maryland, 20817, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sasha Ottey, MHA, MT (ASCP)
PCOS Challenge: The National Polycystic Ovary Syndrome Association
- PRINCIPAL INVESTIGATOR
Ricardo Azziz, MD, MPH, MBA
The University of Alabama at Birmingham
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 5 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 22, 2023
First Posted
April 4, 2023
Study Start
June 22, 2022
Primary Completion (Estimated)
June 1, 2042
Study Completion (Estimated)
December 31, 2042
Last Updated
April 4, 2023
Record last verified: 2023-03
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL
Data obtained through this study may be provided to qualified researchers with academic interest in PCOS. Data or samples shared will be coded, with no PHI included.